SCHEMBL1678773

SCHEMBL1678773

CCCCC([NH])CC

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL277124 0.91
SCHEMBL9207718 0.88 TSHR (0.44)
SCHEMBL7764683 0.88 TSHR (0.44)
SCHEMBL9205016 0.88 TSHR (0.44)
SCHEMBL9211953 0.88 TSHR (0.44)
SCHEMBL9209820 0.88 TSHR (0.44)
SCHEMBL9349389 0.88 TSHR (0.44)
SCHEMBL7761948 0.88 TSHR (0.44)
SCHEMBL9348824 0.88 TSHR (0.44)
SCHEMBL1908388 0.88 TSHR (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
JP-4726304-B2 2011-07-20 JP claimed
WO-2001092420-A2 PERYLENE DYES WITH PERSISTENT FLUORESCENCE CAUSED BY STERIC INHIBITION OF AGGREGATION RADIANT COLOR N.V. (BE) 2001-12-06 WO claimed
US-5081107-A Bombesin or bombesin-like peptides antagonists; anticarcinogenic agents; antisecretory agents; glandular disorders IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-01-14 US claimed
EP-0345990-A2 Polypeptide compounds ZENECA LIMITED (GB) 1989-12-13 EP claimed
US-7923573-B2 Benzene compound having 2 or more substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2011-04-12 US disclosed
US-20080255111-A1 Tissue Factor Production Inhibitor SANKYO COMPANY LIMITED (JP) 2008-10-16 US disclosed
US-20080004301-A1 Benzene Compound Having 2 or More Substituents DAIICHI SANKYO COMPANY, LIMITED (JP) 2008-01-03 US disclosed
EP-1806332-A1 BENZENE COMPOUND HAVING 2 OR MORE SUBSTITUENTS Daiichi Sankyo Company, Limited (JP) 2007-07-11 EP disclosed
EP-1764075-A1 TISSUE FACTOR PRODUCTION INHIBITOR Sankyo Company, Limited (JP) 2007-03-21 EP disclosed
US-20060088786-A1 Rewritable optical information recording medium, recording and reproducing methods, as well as recording and reproducing apparatus MITSUI CHEMICALS, INC. (JP) 2006-04-27 US disclosed
EP-1484191-A1 REWRITABLE OPTICAL INFORMATION RECORDING MEDIUM AND RECORDING/REPRODUCING METHOD, RECORDING/REPRODUCING DEVICE Sony Corporation (JP) 2004-12-08 EP disclosed
US-6476056-B2 ANTIINFLAMMATORY AGENTS, PSYCHOLOGICAL DISORDERS TAISHO PHARMACEUTICAL CO., LTD. (JP) 2002-11-05 US disclosed
US-5081107-A Bombesin or bombesin-like peptides antagonists; anticarcinogenic agents; antisecretory agents; glandular disorders IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1992-01-14 US disclosed
US-5068222-A Polypeptides for treatment of cancer IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1991-11-26 US disclosed
EP-0421441-A2 Pantothenic acid derivatives FUJIREBIO INC. (JP) 1991-04-10 EP disclosed
EP-0345990-A2 Polypeptide compounds ZENECA LIMITED (GB) 1989-12-13 EP disclosed
EP-0315367-A2 Polypeptides IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1989-05-10 EP disclosed
EP-0094804-B1 GLUCOSAMINYL MURAMYL PEPTIDE DERIVATIVES Dainippon Pharmaceutical Co., Ltd. (JP) 1985-11-13 EP disclosed
US-4545932-A NONSPECIFIC RESISTANCE TO MICROBIAL INFECTIONS, IMMUNOSTIMULANTS DAINIPPON PHARMACEUTICAL CO., LTD. (JP) 1985-10-08 US disclosed
EP-0094804-A1 Glucosaminyl muramyl peptide derivatives Dainippon Pharmaceutical Co., Ltd. (JP) 1983-11-23 EP disclosed